
### [NCIT:C4179](http://purl.obolibrary.org/obo/NCIT_C4179)
**Label:** Papillary Cystic Neoplasm

**Subclasses:** [NCIT:C65203](http://purl.obolibrary.org/obo/NCIT_C65203) (Clear Cell Papillary Cystadenoma), [NCIT:C3777](http://purl.obolibrary.org/obo/NCIT_C3777) (Papillary Cystadenocarcinoma), [NCIT:C4180](http://purl.obolibrary.org/obo/NCIT_C4180) (Papillary Serous Cystadenoma), [NCIT:C65204](http://purl.obolibrary.org/obo/NCIT_C65204) (Papillary Mucinous Cystadenocarcinoma), [NCIT:C40142](http://purl.obolibrary.org/obo/NCIT_C40142) (Uterine Ligament Papillary Cystadenoma Associated with von Hippel-Lindau Disease), [NCIT:C2974](http://purl.obolibrary.org/obo/NCIT_C2974) (Papillary Cystadenoma), [NCIT:C7278](http://purl.obolibrary.org/obo/NCIT_C7278) (Ovarian Papillary Cystadenoma), [NCIT:C4186](http://purl.obolibrary.org/obo/NCIT_C4186) (Borderline Papillary Mucinous Cystadenoma), [NCIT:C8377](http://purl.obolibrary.org/obo/NCIT_C8377) (Papillary Serous Cystadenocarcinoma), [NCIT:C4178](http://purl.obolibrary.org/obo/NCIT_C4178) (Borderline Papillary Cystadenoma), [NCIT:C4183](http://purl.obolibrary.org/obo/NCIT_C4183) (Borderline Papillary Serous Cystadenoma), [NCIT:C4184](http://purl.obolibrary.org/obo/NCIT_C4184) (Papillary Mucinous Cystadenoma), 

**Class expressions from DL-Learner:**

- [NCIT:C35999](http://purl.obolibrary.org/obo/NCIT_C35999) (Mucoid Stroma Formation) 57.14%
- [NCIT:C35911](http://purl.obolibrary.org/obo/NCIT_C35911) (Papillary Pattern) 57.14%
- Thing 52.12%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38341](http://purl.obolibrary.org/obo/NCIT_C38341) (Postgerminal Center B-Lymphocyte of Unknown Differentiation Stage))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C3834](http://purl.obolibrary.org/obo/NCIT_C3834) (Ataxic Gait))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38339](http://purl.obolibrary.org/obo/NCIT_C38339) (Postgerminal Center Memory B-Lymphocyte))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38334](http://purl.obolibrary.org/obo/NCIT_C38334) (Postgerminal Center Marginal Zone B-Lymphocyte))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38333](http://purl.obolibrary.org/obo/NCIT_C38333) (Activated B-Lymphocyte))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38332](http://purl.obolibrary.org/obo/NCIT_C38332) (Peripheral B-Lymphocyte of Inner Mantle Zone))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38331](http://purl.obolibrary.org/obo/NCIT_C38331) (Intraepithelial T-Lymphocyte))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38329](http://purl.obolibrary.org/obo/NCIT_C38329) (Thymic B-Lymphocyte))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38328](http://purl.obolibrary.org/obo/NCIT_C38328) (Unfavorable Clinical Outcome))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38327](http://purl.obolibrary.org/obo/NCIT_C38327) (Immature Peripheral Alpha/Beta Cell of Cytotoxic Type))) 42.50%
- [NCIT:C45714](http://purl.obolibrary.org/obo/NCIT_C45714) (Epithelial Tissue) and (not ([NCIT:C38326](http://purl.obolibrary.org/obo/NCIT_C38326) (Immature Peripheral Gamma/Delta Cell of Cytotoxic Type))) 42.50%


